- Nintedanib: Uses, Dosage, Side Effects, Warnings - Drugs. com
Nintedanib is a drug that has been approved by the FDA for some types of Interstitial lung disease (ILD) which have symptoms of shortness of breath, a dry cough, feeling tired and chest discomfort
- Nintedanib - Wikipedia
Nintedanib, sold under the brand names Ofev and Vargatef, is an oral medication used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell lung cancer
- Nintedanib (oral route) - Side effects dosage - Mayo Clinic
Nintedanib is used to treat idiopathic pulmonary fibrosis It helps prevent changes to the lung tissue It is also used to treat people with a chronic (long-lasting) interstitial lung disease in which lung fibrosis continues to progress or becomes worse
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily
- Nintedanib: MedlinePlus Drug Information
Nintedanib is used to treat idiopathic pulmonary fibrosis (IPF; scarring of the lungs with an unknown cause) It is also used to treat certain types of chronic fibrosing interstitial lung diseases (ILD; an ongoing disease in which there is increased scarring of the lungs)
- Ofev (nintedanib) - Uses, Side Effects, and More - WebMD
Ofev (nintedanib) is commonly used to treat certain long-term (chronic) interstitial lung diseases (ILDs) Specifically, it is also used for idiopathic pulmonary fibrosis (IPF) and systemic
- Ofev (nintedanib) dosing, indications, interactions, adverse effects . . .
Medscape - Idiopathic pulmonary fibrosis dosing for Ofev (nintedanib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost
- Nintedanib - patient information
Nintedanib, also known by its brand name, Ofev®, is an anti-fibrotic medicine Anti-fibrotic medicines are designed to slow down the development of scarring (fibrosis) in the lungs
|